Bio-Rad Laboratories Inc. (BIO.B) on Wednesday reported a third-quarter loss of $341.9 million, after reporting a profit in the same period a ...

The outlook for full year 2025 remains unchanged at flat to 1% currency-neutral revenue growth, consistent with the Q2 update. Margins guidance is also unchanged. Q3 reported a slight revenue and ...

The company doesn't seem like it will generate pops in key fundamentals anytime soon.

Bio-Rad Laboratories Inc. reported its earnings for the second quarter of 2025, revealing a modest increase in net sales and a stable financial performance. Despite a challenging market environment, ...

Investing.com - Bio-Rad Labs B (NYSE: BIOb) reported third quarter EPS of $2.26, $0.37 better than the analyst estimate of $1.89.

In context: Since its debut in 2005, Unity has become a fixture of modern game development, powering everything from Cuphead and Hollow Knight to Monument Valley and Genshin Impact. But a newly ...

A code execution vulnerability in the Unity game engine could be exploited to achieve code execution on Android and privilege escalation on Windows. Unity is a cross-platform game engine and ...

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the ...

Unity patches CVE-2025-59489, a high-severity flaw enabling local code execution and data exposure Steam and Valve updated protections; publishers urged to rebuild or patch UnityPlayer.dll in games ...

A vulnerability found in the Unity game engine has led to studio Obsidian Entertainment taking down five of its games, including the premium edition of its 2025 release Avowed. The Unity issue, ...

Some soldiers announce support for protesters Protesters enter heavily-guarded city square for first time Protests pose a serious challenge to President Andry Rajoelina ANTANANARIVO, Oct 11 (Reuters) ...